JPRN-jRCTs071200032已完成未知
PCSK9 Inhibitor Usage on Target Vessel Dysfunction in patients with hypercholesterolemia after coronary stenting, a Multicenter Randomized Controlled Trial - CuVIC-2 Trial
Matoba Tetsuya0 个研究点目标入组 42 人开始时间: 2020年9月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Coronary artery disease patients who underwent successful coronary stenting and will receive investigating lipid-lowering therapy within 8 weeks.
- •Patients whose LDL-C goal is <70mg/dL according to the Japanese Atherosclerosis Sciety Guideline 2022.
- •Patients who have LDL-C Cholesterol equal or more than 70 mg/dL and less than 140mg/dL (Friedewad's formula) under the treatment with high-dose or maximum tolerated dose of statins) with or without ezetimibe.
排除标准
- •Patients who are planned coronary revascularization procedure(s) for residual coronary artery lesion(s).
- •Patients who have undergone a coronary artery bypass grafting.
- •Patients who have severe left ventricular dysfunction (LVEF<30% by ultrasound).
研究者
相似试验
招募中
不适用
Impact of PCSK9 Inhibitor on the Characteristics of Lipid-rich Coronary Plaques Assessed by Near-infrared SpectroscopyIschemic Heart DiseaseJPRN-UMIN000040318Gifu Heart Center50
尚未招募
Unknown
The early administration of PCSK9 inhibitors in patients with acute ischemic stroke and its impact on the prognosis of stroke and changes in lipid profilesDiseases of the circulatory systemKCT0009238Asan Medical Center200
进行中（未招募）
1 期
Studies to gain insight how the drugs PCSK9-inhibitors and statins affect cholesterol and bile acid metabolismHealthy volunteersCTIS2023-505726-34-02Karolinska University Hospital8
进行中（未招募）
1 期
Effect of impact of PCSK9 inhibitor on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular disease proved by myocardial ischemia and needing coronarography.atherosclerotic cardiovascular diseaseEUCTR2019-003360-45-FRniversity Hospital Grenoble66
尚未招募
2 期
PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSSColorectal CancerNCT06391905Guangdong Provincial People's Hospital60